KalVista Pharmaceuticals (KALV) Stock Highlights

8.36 | +3.34%

2024-12-21 05:18:56

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The companys product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

Statistics

Range Today

7.97 8.55

Volume Today 1.01M

Range 1 Year

8.07 16.88

Volume 1 Year 119.74M

Range 3 Year

4.12 17.34

Volume 3 Year 261.06M

Range 10 Year

4.12 129.108

Volume 10 Year 481.76M

Highlights

Market Capitalization 561.55M (small)

Floating Shares 26.08M

Current Price 8.36

Price To Earnings -3.13

Price To Book 2.84

Earnings Per Share -3.57

Payout Ratio 0%

Performance

Latest +3.34%

1 Month -7.11%

3 Months -23.86%

6 Months -26.21%

1 Year -24.07%

3 Years -35.24%

5 Years -50.44%

10 Years -90.81%

Benchmarks

Market Capitalization

160 / 368

Gross Profits

225 / 278

Total Revenue

0 / 300

Total Rank

327 / 368

Free Cashflow

191 / 352

Performance 5 years

169 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.